HEALTHCARE INNOVATION
Bringing Diagnostic Healthcare Within Reach
MedInno Technologies develops affordable molecular diagnostic products, delivers advanced laboratory testing services, and enables end-to-end mass screening programmes to make quality healthcare more accessible across India.
WHAT WE DO
Products
We develop and manufacture affordable molecular diagnostic kits and instruments, including nucleic acid extraction kits, RT-PCR kits, extraction instruments, and real-time PCR systems designed for reliable testing in diverse laboratory settings.
Laboratory Services
Our advanced laboratory services include Next-Generation Sequencing (NGS), Real-Time PCR testing, and specialised molecular diagnostics, supported by our Bangalore laboratory.
Mass Screening Programmes
We partner with governments, NGOs, healthcare organisations, and industry partners to deliver end-to-end mass screening programmes for infectious diseases, oncology, and genetic health using diagnostics, field operations, and real-time reporting.
WHY CHOOSE US
Built to Bring Healthcare Closer to You
Products built for real labs. Services designed for real patients. Screening that reaches people who need it most.
Reaching Communities Through nationwide screening programs
Explore Our WorkPan-India Presence
Community Screening
Built to Scale Supporting affordable diagnostics for every region
InnoExtract - Low-cost DNA Extraction Device
InnoMag & InnoSpin - DNA extraction kits - magnetic bead-based and spin-column-based
InnoQuant - Low cost real-time PCR (RT PCR) machine
InnoAmp - Real-time PCR kits for diagnostic and research use
OUR VERTICALS
Integrated solutions spanning products, laboratory services, and public health programmes.
Clinical Services
Our Bangalore laboratory handles testing across genetics, mother and child health, oncology, and general wellness. Infectious disease testing is coming soon.
Product Development
We develop affordable molecular diagnostic products, including InnoExtract, InnoMag, InnoSpin, InnoQuant, and InnoAmp, built for labs that need reliable molecular testing without prohibitive infrastructure requirements. Each product is developed to work in real laboratory conditions, from busy urban facilities to smaller regional labs.
Community Screening
We partner with governments, NGOs, and public health organisations to deliver end-to-end mass screening programmes for conditions such as tuberculosis, cervical cancer, breast cancer, sickle cell disease, and maternal health. By combining diagnostic products, laboratory services, field execution, and real-time data reporting, we help bring reliable screening and earlier detection to underserved communities.
R&D and Contract Services
We offer assay development, genetic testing, Ion Torrent next-generation sequencing, and AI/ML-based diagnostic solutions to partners across the healthcare industry. Our R&D team works alongside hospitals, research institutions, and diagnostic companies to bring new tests from concept to deployment.
Insights Research, and Field Stories
Precision Diagnostics
Transforming disease detection through advanced molecular diagnostics, enabling faster and more accurate healthcare decisions.
Healthcare Innovation
Developing affordable healthcare technologies that bridge diagnostic gaps and improve access across communities.
Genomics Research
Advancing genomics-driven insights to support personalized medicine and next-generation diagnostic solutions.
Have Questions?
We're Here To Help
We work with governments, NGOs, hospitals, and laboratories to bring accurate, affordable diagnostics to more communities across India.
Contact
admin@medinno.inHow do we set up a screening programme?
Setting up a screening programme starts with understanding your target population, screening objectives, and operational requirements. MedInno works with healthcare organisations, NGOs, hospitals, and government agencies to plan and execute programmes with diagnostic products, laboratory support, field operations, sample collection, and structured reporting tailored to programme needs.
What type of screenings are available?
MedInno supports screening programmes for tuberculosis, HPV and cervical cancer, sickle cell disease, maternal health, and other priority public health conditions. Depending on the programme, we provide diagnostic products, laboratory services, field implementation, and reporting support in collaboration with healthcare institutions, NGOs, and government partners.
How much does screening cost?
The cost of a screening programme depends on factors such as the target population, testing volume, location, and programme scope. MedInno works with each organisation to develop a solution that balances affordability with reliable diagnostic performance. Contact our team to discuss your requirements and receive a customized proposal.
How can we partner?
MedInno partners with hospitals, diagnostic laboratories, government agencies, NGOs, academic institutions, and corporate organisations. Collaborations may include molecular diagnostic products, laboratory testing services, screening programme implementation, or end-to-end support covering planning, execution, reporting, and technical assistance based on your project requirements.
Do you work nationwide?
MedInno operates through its Bangalore laboratory and works with healthcare partners to support molecular diagnostics and screening programmes. Please contact our team to discuss service availability for your location.
What technologies do you use?
MedInno develops and supports molecular diagnostic solutions, including nucleic acid extraction technologies and real-time PCR assays for infectious disease detection and other clinical applications. Our portfolio also includes laboratory testing services such as real-time PCR and next-generation sequencing to support diagnostic and research requirements.
Are you associated with research institutions?
Yes. MedInno collaborates with academic institutions, research organisations, healthcare partners, and industry to support assay development, genetic testing, next-generation sequencing, and related research activities. These collaborations help advance molecular diagnostics while supporting clinical, public health, and scientific research initiatives.